At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
03160 CAM JAPAN HDG
Market Closed 03-20 15:45:02
28.420
+0.220
+0.78%
High28.440Low28.340Vol43.22K
Open28.440D1 Closing28.200Amplitude0.35%
Mkt Cap1.82BTradable Cap611.03MTotal Shares64.20M
T/O1.23MT/O Rate0.20%Tradable Shares21.50M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Press Release: Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering
Dow Jones  ·  14 minutes ago
Press Release: Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering
Press Release: Capital Group Canada Announces Cash Distribution for Capital Group Canada ETFs (CAPM, CAPW)
Dow Jones  ·  05:00
Press Release: Capital Group Canada Announces Cash Distribution for Capital Group Canada ETFs (CAPM, CAPW)
Press Release: Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations
Dow Jones  ·  03-20 21:03
Press Release: Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations
Press Release: Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST(TM) (etripamil) Nasal Spray for the Treatment of PSVT
Dow Jones  ·  03-20 19:12
Press Release: Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST(TM) (etripamil) Nasal Spray for the Treatment of PSVT
Press Release: Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer
Dow Jones  ·  03-20 19:00
Press Release: Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer
Press Release: The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share
Dow Jones  ·  03-20 18:00
Press Release: The Ensign Group, Inc. Declares Quarterly Dividend of $0.0650 Per Share
Press Release: Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability
Dow Jones  ·  03-20 17:06
Press Release: Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability
Press Release: Samsonite Group S.A. Announces Results for the Year Ended December 31, 2025
Dow Jones  ·  03-20 07:45
Press Release: Samsonite Group S.A. Announces Results for the Year Ended December 31, 2025
Press Release: Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Dow Jones  ·  03-20 04:12
Press Release: Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Press Release: electroCore Announces Full Year 2025 Financial Results and Organizational Changes
Dow Jones  ·  03-20 04:05
Press Release: electroCore Announces Full Year 2025 Financial Results and Organizational Changes
Press Release: CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER
Dow Jones  ·  03-19 20:15
Press Release: CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER
Press Release: Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives
Dow Jones  ·  03-19 20:00
Press Release: Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives
Press Release: BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health
Dow Jones  ·  03-19 19:30
Press Release: BrainsWay Completes Revenue-Based Milestone Investment into Axis Integrated Mental Health
Press Release: Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results
Dow Jones  ·  03-19 18:30
Press Release: Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results
Yomiuri: Toyota Tsusho Joins Rare Earth Development Project in Namibia
Dow Jones  ·  03-19 17:56
Yomiuri: Toyota Tsusho Joins Rare Earth Development Project in Namibia
SoftBank Project Fee Slashed By Over 90% Amid Uncertainty Over $550 Billion US-Japan Trade Deal: Report
Benzinga_recent_news  ·  03-19 17:32
SoftBank Project Fee Slashed By Over 90% Amid Uncertainty Over $550 Billion US-Japan Trade Deal: Report
Press Release: Alibaba Group Announces December Quarter 2025 Results
Dow Jones  ·  03-19 17:30
Press Release: Alibaba Group Announces December Quarter 2025 Results
Press Release: Alvotech Q4 2025 and Full Year 2025 Financial Results
Dow Jones  ·  03-19 06:15
Press Release: Alvotech Q4 2025 and Full Year 2025 Financial Results
Press Release: ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
Dow Jones  ·  03-19 04:05
Press Release: ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
Press Release: Hudson Technologies Announces Management Appointments to Strengthen Operations, Extend Market Reach and Accelerate Growth
Dow Jones  ·  03-19 04:05
Press Release: Hudson Technologies Announces Management Appointments to Strengthen Operations, Extend Market Reach and Accelerate Growth

Introduction

Company Name.
CAM JAPAN HDG
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Issue price:
--